Jean Jacques Bienaime - May 10, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 10, 2021
Transactions value $
-$432,460
Form type
4
Date filed
5/12/2021, 07:21 PM
Previous filing
May 10, 2021
Next filing
May 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $226K +8.51K +2.8% $26.49 312K May 10, 2021 Direct F1
transaction BMRN Common Stock Sale -$658K -8.51K -2.73% $77.29 304K May 10, 2021 Direct F1
holding BMRN Common Stock 248K May 10, 2021 Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -8.51K -100% $0.00* 0 May 10, 2021 Common Stock 8.51K $26.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.